Vista Pharmaceuticals
10.10
+0.43(+4.45%)
Market Cap₹62.15 Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D+4.45%
1M-4.27%
6M+0.20%
1Y-21.34%
5Y+7.10%
View Company Insightsright
Latest news about Vista Pharmaceuticals
Vista Pharmaceuticals Reports Widened Quarterly Loss, Reappoints Key Executives Aug 13, 2025
Vista Pharmaceuticals Limited reported a net loss of Rs. 129.04 crore for Q1 FY2026, compared to Rs. 85.70 crore loss in Q1 FY2025. Revenue declined 15.4% to Rs. 151.88 crore. The company reappointed three key executives - Mr. Murali Meraga as Managing Director, Mr. Pavan Sathvik Gilaka and Mr. Dhananjaya Alli as Whole-time Directors for three-year terms. The 34th AGM is scheduled for September 30, 2025, via video conferencing. Book closure dates are set from September 24 to 30, 2025.